Frontiers | The Efficacy and Safety of the Combined Therapy of Sodium-Glucose Co-Transporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitor in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced
Frontiers | Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction and Advanced Chronic Kidney Disease: A Retrospective Multi-Institutional Study
Will introduction of ARNI reduce the need of device therapy in heart failure with reduced ejection fraction? | The Egyptian Heart Journal | Full Text
Place in therapy of ARNI according European Society of Cardiology... | Download Scientific Diagram